NCT03209271

Brief Summary

Fluid boluses are often administered with the aim of improving tissue perfusion in critically ill patients. It is unclear whether the temperature of the fluid has an impact on the hemodynamic response. The aim of this study is to describe the hemodynamic effects of a fluid bolus with two different temperatures.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
21

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 3, 2017

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 27, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 27, 2017

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

June 26, 2017

Completed
10 days until next milestone

First Posted

Study publicly available on registry

July 6, 2017

Completed
Last Updated

July 6, 2017

Status Verified

July 1, 2017

Enrollment Period

4 months

First QC Date

June 26, 2017

Last Update Submit

July 3, 2017

Conditions

Keywords

Fluid therapy

Outcome Measures

Primary Outcomes (1)

  • Cardiac index 15 minutes

    Change in cardiac index at 15 minutes from start of infusion

    15 minutes

Secondary Outcomes (4)

  • Cardiac index 120 minutes

    120 minutes

  • Blood pressure 120 minutes

    120 minutes

  • Heart rate 120 minutes

    120 minutes

  • Temperature 120 minutes

    120 minutes

Other Outcomes (4)

  • Time to return to baseline for CI

    0-120 minutes

  • Time to return to baseline for blood pressure

    0-120 minutes

  • Time to return to baseline for heart rate

    0-120 minutes

  • +1 more other outcomes

Study Arms (2)

Body temperature fluid

EXPERIMENTAL

500ml Ringers Acetate infused over 15 minutes warmed to 38°C

Drug: Ringer's Acetate (warm)

Room temperature fluid

ACTIVE COMPARATOR

500ml Ringers Acetate infused over 15 minutes cooled to 22°C

Drug: Ringer's Acetate (cold)

Interventions

Body temperature fluid

Also known as: Ringer-Acetat Baxter Viaflo, ATC B05BB01
Body temperature fluid

Room temperature fluid

Also known as: Ringer-Acetat Baxter Viaflo, ATC B05BB01
Room temperature fluid

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \- Volunteers 18 years or older Previously healthy

You may not qualify if:

  • American Society of Anesthesiologists classification 2 or above.
  • Known pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Karolinska Institutet Södersjukhuset

Stockholm, 118 83, Sweden

Location

Related Publications (1)

  • Wall O, Ehrenberg L, Joelsson-Alm E, Martensson J, Bellomo R, Svensen C, Cronhjort M. Haemodynamic effects of cold versus warm fluid bolus in healthy volunteers: a randomised crossover trial. Crit Care Resusc. 2018 Dec;20(4):277-284.

MeSH Terms

Conditions

Body Temperature ChangesHypovolemia

Interventions

Ringer's acetateCold Temperature

Condition Hierarchy (Ancestors)

Signs and SymptomsPathological Conditions, Signs and SymptomsPathologic Processes

Intervention Hierarchy (Ancestors)

TemperatureThermodynamicsPhysical PhenomenaWeatherAtmosphereEnvironmentEcological and Environmental PhenomenaBiological PhenomenaMeteorological ConceptsEnvironment and Public Health

Study Officials

  • Maria Cronhjort, MD, PhD

    Karolinska Institutet

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
Unblinded (unable to blind subjects)
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Model Details: Crossover study of 2 different temperatures of crystalloid fluid bolus.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

June 26, 2017

First Posted

July 6, 2017

Study Start

February 3, 2017

Primary Completion

May 27, 2017

Study Completion

May 27, 2017

Last Updated

July 6, 2017

Record last verified: 2017-07

Data Sharing

IPD Sharing
Will not share

Locations